Addus HomeCare Director Gets 1,172 Restricted Shares 鈥� Insider Filing

Q: How many Addus HomeCare shares did Director Esteban Lopez acquire in the June 2025 Form 4?

He acquired 1,172 restricted shares of common stock.

Q: When will the restricted shares granted to Esteban Lopez vest?

The shares will vest in full on June 18, 2026 .

Q: What is Esteban Lopez鈥檚 total beneficial ownership after the reported transaction?

After the grant, Lopez beneficially owns 4,538 shares directly.

Q: Did the Form 4 disclose any sale of Addus HomeCare stock?

No. The filing reports only an acquisition ; there were no sales or disposals of shares.

Q: Why did Addus HomeCare file this Form 4?

The company filed to comply with Section 16 reporting rules after a director鈥檚 change in beneficial ownership from a routine equity award.

[Form 4] Addus HomeCare Corp. Insider Trading Activity

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Addus HomeCare (NASDAQ:ADUS) filed a Form 4 reporting that non-employee director Esteban Lopez received 1,172 restricted shares of common stock on 06/18/2025 at no cost. The grant will vest in full on 06/18/2026. Following the award, Lopez directly owns 4,538 shares of ADUS. No sales, options exercises, or cash transactions were disclosed.

This filing reflects routine board equity compensation and does not signal any change in the company鈥檚 financial condition, operations, or strategic direction.

Insights

Routine director stock grant; neutral for valuation

The Form 4 shows a standard annual equity award of 1,172 restricted shares to director Esteban Lopez, increasing his stake to 4,538 shares. The absence of sales or large value transfers points to ordinary-course compensation rather than an insider view on near-term share performance. There are no red flags regarding Rule 10b5-1 usage or unusual timing. As such, the disclosure is immaterial to current investors beyond standard transparency requirements.

06/20/2025 - 04:30 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lopez Esteban

(Last)

(First)

(Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO

75034

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/18/2025		A		1,172⁽¹⁾	A	$0	4,538	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted shares granted to non-employee directors that will vest in full on June 18, 2026.

	/s/ Brian Poff, Attorney-In-Fact for Esteban Lopez	06/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

How many Addus HomeCare shares did Director Esteban Lopez acquire in the June 2025 Form 4?

He acquired 1,172 restricted shares of common stock.

When will the restricted shares granted to Esteban Lopez vest?

The shares will vest in full on June 18, 2026.

What is Esteban Lopez鈥檚 total beneficial ownership after the reported transaction?

After the grant, Lopez beneficially owns 4,538 shares directly.

Did the Form 4 disclose any sale of Addus HomeCare stock?

No. The filing reports only an acquisition; there were no sales or disposals of shares.

Why did Addus HomeCare file this Form 4?

The company filed to comply with Section 16 reporting rules after a director鈥檚 change in beneficial ownership from a routine equity award.

AG真人官方

[Form 4] Addus HomeCare Corp. Insider Trading Activity

Insights

FAQ

How many Addus HomeCare shares did Director Esteban Lopez acquire in the June 2025 Form 4?

When will the restricted shares granted to Esteban Lopez vest?

What is Esteban Lopez鈥檚 total beneficial ownership after the reported transaction?

Did the Form 4 disclose any sale of Addus HomeCare stock?

Why did Addus HomeCare file this Form 4?

NASDAQ:ADUS

ADUS Rankings

ADUS Latest News

ADUS Latest SEC Filings

ADUS Stock Data

AG真人官方

Trending News

[Form 4] Addus HomeCare Corp. Insider Trading Activity

Insights

Corporate Governance Expert neutral

FAQ

How many Addus HomeCare shares did Director Esteban Lopez acquire in the June 2025 Form 4?

When will the restricted shares granted to Esteban Lopez vest?

What is Esteban Lopez鈥檚 total beneficial ownership after the reported transaction?

Did the Form 4 disclose any sale of Addus HomeCare stock?

Why did Addus HomeCare file this Form 4?

NASDAQ:ADUS

ADUS Rankings

ADUS Latest News

ADUS Latest SEC Filings

ADUS Stock Data